Eterna Therapeutics Announces Positive Preclinical Study Results on Lead Product ERNA-101 ...
New data from proof-of-concept study provides roadmap for treatment of ovarian cancerCAMBRIDGE, Mass., Jan. 14, 2025 (GLOBE ...
AZoNano on MSN3 小时
Novel Nanobody Inhibitors Against Ebola Virus: Nanosota-EB1 and Nanosota-EB2
A recent study evaluates the potential of Nanosota-EB1 and Nanosota-EB2, nanobody inhibitors targeting the Ebola virus.
Scientific Research Publishing7 小时
Protective Effect of Liraglutide on Early Renal Fibrosis in Diabetes Mice ()
Ke, X. and Ma, T. (2025) Protective Effect of Liraglutide on Early Renal Fibrosis in Diabetes Mice. Journal of Biosciences and Medicines, 13, 84-91. doi: 10.4236/jbm.2025.131008 .